Janus Henderson Group plc 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 10:46 am Sale | 2025-06-30 | 13G | Entrada Therapeutics, Inc. TRDA | JANUS HENDERSON GROUP PLC JHG | 1,521,281 4.000% | -600,373 (-28.30%) | Filing |
| 2025-05-14 12:28 pm Purchase | 2025-03-31 | 13G | Entrada Therapeutics, Inc. TRDA | JANUS HENDERSON GROUP PLC JHG | 2,121,654 5.600% | 41,287 (+1.98%) | Filing |
| 2025-02-14 11:25 am Purchase | 2024-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | JANUS HENDERSON GROUP PLC JHG | 2,080,367 5.600% | 2,080,367 (New Position) | Filing |